TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
39.49
+1.50 (3.95%)
Apr 23, 2025, 4:00 PM EDT - Market closed
TG Therapeutics Employees
TG Therapeutics had 338 employees as of December 31, 2024. The number of employees increased by 74 or 28.03% compared to the previous year.
Employees
338
Change (1Y)
74
Growth (1Y)
28.03%
Revenue / Employee
$973,385
Profits / Employee
$69,180
Market Cap
5.74B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
TGTX News
- 13 days ago - TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting - GlobeNewsWire
- 16 days ago - TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals - GlobeNewsWire
- 4 weeks ago - Stock Of The Day: TG Therapeutics Breaks Out, May Head Higher - Benzinga
- 5 weeks ago - Precision & TG Therapeutics: Unlocking Value With ARCUS, BRIUMVI And Azer-Cel - Seeking Alpha
- 5 weeks ago - TG Therapeutics: Bright Outlook, Bolstered By Briumvi And Upcoming Trials - Seeking Alpha
- 6 weeks ago - TG Therapeutics: Exciting Briumvi Performance, Looking To Re-Enter - Seeking Alpha
- 6 weeks ago - TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting - GlobeNewsWire
- 7 weeks ago - Privia Health, Corcept and three other low-key but high-earnings growth potential stocks to invest in 2025 - Invezz